Both in Pharmaceuticals
Actinium Pharmaceuticals vs Aldeyra Therapeutics
Over the past year ATNM returned −6.8% and ALDX returned −86.7%; their daily moves had a correlation of -0.04.
ATNM −6.8% ALDX −86.7%Growth of $1, one year, split-adjusted
| Metric | ATNM | ALDX |
|---|---|---|
| Price | $1.38 | $0.6836 |
| Market cap | $43.4M | $41.2M |
| Today | −2.82% | +6.61% |
| 1 month | +21.1% | −48.2% |
| 6 months | +17.9% | −54.4% |
| Year to date | +1.5% | −86.8% |
| 1 year | −9.8% | −86.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | 79.7% | — |
| P/E (TTM) | 3.8× | — |
| Price / sales | 1.2× | — |
| Net cash | $36.5M | $45.1M |
| Dividend yield | — | — |
| Volatility (60d) | 90.1% | 88.3% |
| Short % of float | 2.0% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).